Strengthened leadership team with key appointments, including Barry Quart, Pharm.D. as CEO, and David Szekeres as President, bringing deep ...

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibrosis and severe ...

JPMorgan initiated coverage of Mereo BioPharma (MREO) with an Overweight rating and $7 price target The company’s company’s current valuation creates an attractive entry point ahead of the ...

But the promise of AI in biopharma is equally tempered by the long journey ahead and the technology’s many uncertainties. For this year’s State of Tech in Biopharma report, we were deeply ...

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of ...

Sunshine Biopharma (SBFM) announced that is has signed a strategic agreement granting it the rights to market two new generic antibiotics in Canada. The Company anticipates launching these new ...

Healthcare & Pharmaceuticalscategory· March 26, 2025 Bayer acquires rights in Puhe BioPharma cancer drug candidate Bayer said on Wednesday it struck a global licence agreement for an experimental ...

SEC Filings provided by EDGAR Online, Inc.

Researching and developing therapeutic products for human use.